Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering

• US 7,625,580 B1
• Filed: 11/28/2000
• Issued: 12/01/2009
• Est. Priority Date: 11/28/2000
• Status: Expired due to Fees

• Current Assignee: The Board of Regents of the University of Colorado (University of Colorado System)
• Original Assignee: Massachusetts Institute of Technology
• Inventors: Sims, Derek, Elisseeff, Jennifer, Langer, Robert S., Anseth, Kristi
• Primary Examiner(s): Azpuru; Carlos A.
• Application Number:
  US09/724,382
• Time in Patent Office: 3,290 Days
• Field of Search: 424/425, 424/486, 424/423, 424/426, 525/903, 525/937, 523/113, 523/114, 523/115, 523/116
• US Class Current: 424/426
• CPC Class Codes: A61L 2400/06 Flowable or injectable implant compositions
• CPC Class Codes: A61L 2430/06 for cartilage reconstruction, e.g. meniscus
• CPC Class Codes: A61L 27/38 containing added animal cells organs or tissue containing native cells A61L27/36
• CPC Class Codes: A61L 27/3817 Cartilage-forming cells, e.g. pre-chondrocytes
• CPC Class Codes: A61L 27/3852 Cartilage, e.g. meniscus
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 27/52 Hydrogels or hydrocolloids

Abstract

Compositions for tissue engineering and drug delivery have been developed based on solutions of two or more polymers which form semi-interpenetrating or interpenetrating polymer networks upon exposure to active species following injection at a site in a patient in need thereof. The polymers crosslink to themselves but not to each other; semi-interpenetrating networks are formed when only one of the polymers crosslink. The resulting viscous solutions retain the biologically active molecules or cells at the site of injection until release or tissue formation, respectfully, occurs.

As a result of studies conducted with polymer-cell suspensions forming interpenetrating polymer networks, it has been determined that polymer solutions can be formulated wherein the active species is provided by exposure of the polymer solution to an exogenous source of active species, typically electromagnetic radiation, preferably light. Studies demonstrate that light will penetrate through skin, body fluids (such as synovial fluid) and membranes and polymerize the polymer solutions. The polymer solutions can be crosslinked ionically or covalently, to form a hydrogel, semi-interpenetrating polymer network or an interpenetrating polymer network.

Claims

1. A method for making semi-interpenetrating or interpenetrating polymer networks, comprising:

exposing a suspension of dissociated cells in a solution of two or more biocompatible polymers to free radicals generated during photopolymerization using a light source external to the suspension so that the light generates free radicals thereby forming the semi-interpenetrating or interpenetrating polymer networks.

2. The method of claim 1, wherein the semi-interpenetrating or interpenetrating polymer networks are cartilage tissue equivalents.

3. The method of claim 2 wherein the light is selected from the group consisting of ultraviolet radiation, long-wavelength ultraviolet radiation, and visible light.

4. The method of claim 2 wherein the suspension further comprises a photoinitiator.

5. The method of claim 4 wherein the photoinitiator is selected from the group consisting of erythrosin, phloxime, rose bengal, thonine, camphorquinone, ethyl eosin, eosin, methylene blue, riboflavin, 2,2-dimethyl-2-phenylacetophenone, 2-methoxy-2 phenylacetophenone, 2,2-dimethoxy-2-phenylacetophenone, and other acetophenone derivatives.

6. The method of claim 5 wherein the suspension further comprises a cocatalyst.

7. The method of claim 6 wherein the cocatalyst is selected from the group consisting of N-methyl diethanolamine, N,N-dimethyl benzylamine, triethanolamine, triethylamine, dibenzylamine, N-benzylethanolamine, and N-isopropyl benzylamine.

8. The method of claim 7 wherein the cocatalyst is triethanolamine.

9. A method of forming a tissue equivalent in a subject, the tissue equivalent comprising semi-interpenetrating or interpenetrating networks, comprising:

injecting a suspension of dissociated cells in a solution of two or more biocompatible polymers into a subject, and

exposing the suspension to free radicals generated during photopolymerization using a light source external to the injected suspension so that the light penetrates through tissue to generate free radicals thereby forming the tissue equivalent.

10. The method of claim 9 wherein the x-rays, ultrasound, infrared radiation, far infrared radiation, ultra-violet radiation, long-wavelength ultraviolet radiation, or visible light is applied externally to the skin.

11. The method of claim 9 wherein the light is selected from the group consisting of ultra-violet radiation, long-wavelength ultraviolet radiation, or visible light and is applied within a synovial space to a polymer-cell suspension injected into an adjacent joint.

12. A method of forming a tissue equivalent in a mold, the tissue equivalent comprising semi-interpenetrating or interpenetrating polymer networks, comprising:

injecting a suspension of dissociated cells in a solution of two or more biocompatible polymers into a mold, and

exposing the suspension to free radicals generated during photopolymerization using a light source external to the suspension so that the electromagnetic radiation generates free radicals thereby fong the tissue equivalent.